Compare ASTS & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASTS | HOLX |
|---|---|---|
| Founded | 2019 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical Electronics |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.4B | 16.6B |
| IPO Year | N/A | 1990 |
| Metric | ASTS | HOLX |
|---|---|---|
| Price | $74.03 | $74.98 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 15 |
| Target Price | $59.37 | ★ $79.64 |
| AVG Volume (30 Days) | ★ 10.6M | 3.0M |
| Earning Date | 11-10-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.49 |
| Revenue | $18,531,000.00 | ★ $4,100,500,000.00 |
| Revenue This Year | $1,223.27 | $6.69 |
| Revenue Next Year | $363.99 | $5.74 |
| P/E Ratio | ★ N/A | $30.11 |
| Revenue Growth | ★ 641.24 | 1.74 |
| 52 Week Low | $17.50 | $51.90 |
| 52 Week High | $102.79 | $80.31 |
| Indicator | ASTS | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 62.62 | 67.93 |
| Support Level | $52.20 | $74.55 |
| Resistance Level | $57.81 | $75.12 |
| Average True Range (ATR) | 5.09 | 0.28 |
| MACD | 2.14 | -0.14 |
| Stochastic Oscillator | 95.81 | 78.92 |
AST SpaceMobile Inc is a satellite designer and manufacturer. The company is building a cellular broadband network in space to operate directly with standard, unmodified mobile devices, and off-the-shelf mobile phones based on extensive IP and patent portfolio. It has focused on eliminating the connectivity gaps faced by mobile subscribers. The Company's spaceMobile Service is being designed to provide cost-effective, high-speed Cellular Broadband services to end-users who are out of terrestrial cellular coverage using existing mobile devices.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.